Anti-Mouse PSCA Antibody (SAA2225), FITC

Catalog No.

FMA73511

Species reactivity

Mouse

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Conjugation

FITC

Target

Prostate stem cell antigen, PSCA

Endotoxin level

Please contact with the lab for this information.

Purification

Affinity chromatography.

Accession

P57096

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA2225

A facile yeast-display approach for antibody mask discovery., PMID:40381213

Impact of tumor localization on antitumor immunity with conditionally activated CTLA-4 blockade., PMID:40180419

Targeting the tumour cell surface in advanced prostate cancer., PMID:40169837

Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies., PMID:39272956

Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival., PMID:39232121

Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer., PMID:39113562

T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer., PMID:38801069

64Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates., PMID:38506263

Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer., PMID:37660477

Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer., PMID:37378940

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer., PMID:37359737

Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5., PMID:37298374

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy., PMID:36817127

Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management., PMID:35454902

Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers., PMID:35454835

Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer., PMID:34675084

Post-transplant Cyclophosphamide Versus Thymoglobulin in HLA-Mismatched Unrelated Donor Transplant for Acute Myelogenous Leukemia and Myelodysplastic Syndrome., PMID:34174469

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors., PMID:34066833

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens., PMID:33884106

The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells., PMID:33176663

Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy., PMID:32815673

Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer., PMID:32661830

In Pursuit of Stability Enhancement of a Prostate Cancer Targeting Antibody Derived from a Transgenic Animal Platform., PMID:32546687

Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self., PMID:32451262

Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model., PMID:32016503

Tri-functional platform for construction of modular antibody fragments for in vivo 18F-PET or NIRF molecular imaging., PMID:34123276

Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer., PMID:31839644

In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless., PMID:31380306

[89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model., PMID:31209779

A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for 18F-Immuno-PET and Fluorescence Imaging., PMID:30877181

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis., PMID:30824859

Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody., PMID:30613270

Quantum dot-based fluorescent probes for targeted imaging of the EJ human bladder urothelial cancer cell line., PMID:30546399

Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models., PMID:30301826

Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators., PMID:30180567

Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody., PMID:29602820

Evaluation of a Pretargeting Strategy for Molecular Imaging of the Prostate Stem Cell Antigen with a Single Chain Antibody., PMID:29491468

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients., PMID:29122836

Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice., PMID:28939158

Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression., PMID:28903367

Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?, PMID:28795218

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer., PMID:28667390

Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling., PMID:28472300

Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer., PMID:27783810

Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)-Targeted Photothermal Therapy., PMID:27659802

Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time., PMID:26490315

Nanoparticle mediated chemotherapy of hormone refractory prostate cancer with a novel combi-molecule., PMID:26396674

A genome-wide association study for clinical mastitis in first parity US Holstein cows using single-step approach and genomic matrix re-weighting procedure., PMID:25658712

Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer., PMID:25326233

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells., PMID:25053504

Document Download

Anti-Mouse PSCA Antibody (SAA2225), FITC.pdf